Some men with low-risk prostate cancer will never need treatment, and staying on Active Surveillance remains the option with the lowest risk of erectile dysfunction and urinary side effects. But for men who do need treatment, understanding how different options may affect sexual function is an important part of making an informed decision. In this excerpt from the Blue Cure Men’s Health Podcast, Kristen Scarpato, MD, MPH — Urologic Oncologist and Associate Professor of Urology at Vanderbilt Univ